Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Duct To Mucosa Pj Group

Research Leaders

5 sponsors active, led by Hospital Universitario Virgen de la Arrixaca

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 1 (1)

Trial Status

Completed2
Unknown2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Duct To Mucosa Pj Group1
  • Pancreatico Gastro Anastomosis1
  • Blumgart Anastomosis1
  • Pancreaticojejuno Anastomosis1
  • Pancreatogastric Anastomosis1

Active Sponsors

  • Hospital Universitario Virgen de la Arrixaca1
  • Fundación para la Investigación del Hospital Clínico de Valencia1
  • Instituto de Salud Carlos III1
  • University of Belgrade1
  • Mansoura University1

Top Investigators

Related Conditions

  • Pancreatic Cancer2
  • Pancreatic Neoplasms1
  • Stent Disintegration1
  • Pancreas Neoplasm1
  • Pancreatic Fistula1

Activity Timeline